Skip to main content
DNA Labs India

MT-TS2 Gene MERRF/MELAS overlap syndrome, MT-TS2 related NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

MT-TS2 Gene MERRF/MELAS overlap syndrome, MT-TS2 related NGS Genetic Test

Short Name: MT-TS2 NGS Test

Also known as: MT-TS2 gene mutation test, MERRF/MELAS overlap syndrome NGS panel, Mitochondrial DNA MT-TS2 analysis

MT-TS2 Gene MERRF/MELAS overlap syndrome, MT-TS2 related NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS), Bioinformatics Analysis on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks after the sample reaches the laboratory. The report will be accompanied by raw data files (FASTQ, VCF) for transparency and further analysis if needed.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the MT-TS2 related NGS genetic test is to identify mutations in the MT-TS2 gene that are associated with MERRF/MELAS overlap syndrome. This test is intended for individuals presenting with clinical features suggestive of mitochondrial encephalomyopathy, unexplained seizures, stroke-like episodes, myopathy, ophthalmoplegia, hearing loss, or cognitive decline. It helps confirm the diagnosis, supports medical management, and enables genetic counselling for at-risk family members.

Test Code
4287
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks after the sample reaches the laboratory. The report will be accompanied by raw data files (FASTQ, VCF) for transparency and further analysis if needed.
Fasting Required
No
Method
Next-Generation Sequencing (NGS), Bioinformatics Analysis
Step 1

Sample Collection

No fasting required. A genetic counselling session is recommended before testing to discuss the purpose, limitations, and implications of the test. Please bring previous medical records and any family history information.

Method: Peripheral venipuncture / Finger-prick blood spot

Step 2

Laboratory Analysis

For blood samples, a simple venipuncture is performed by a trained phlebotomist. FTA card blood spot collection involves a small finger-prick. The process takes only a few minutes.

Step 3

Report Delivery

Resume normal activities immediately. There are no specific aftercare instructions. The sample will be sent to the laboratory for analysis. Results are typically available in 3 to 4 weeks.

Timeline: Results are typically available within 3 to 4 weeks after the sample reaches the laboratory. The report will be accompanied by raw data files (FASTQ, VCF) for transparency and further analysis if needed.

Patient Instructions

1
Before the Test:Before taking the test, you will have a genetic counselling session. This helps you understand the inheritance pattern, the implications of possible positive or negative results, and the psychological and emotional impact. Please prepare your full medical history and any family records of neurological disorders.
2
During the Test:During the test, a small sample of blood or DNA is collected. For blood, a needle is inserted into a vein and the blood is drawn into a tube. For FTA cards, a few drops of blood are placed on the card. You may feel a mild prick but no significant pain.
3
After the Test:After providing the sample, you can leave and resume normal activities. The sample will be processed in our NGS laboratory. Reporting is done through an online portal, email, or WhatsApp. Our laboratory may contact you if the results require urgent clinical attention.

About This Test

Who Should Get This Test

The purpose of the MT-TS2 related NGS genetic test is to identify mutations in the MT-TS2 gene that are associated with MERRF/MELAS overlap syndrome. This test is intended for individuals presenting with clinical features suggestive of mitochondrial encephalomyopathy, unexplained seizures, stroke-like episodes, myopathy, ophthalmoplegia, hearing loss, or cognitive decline. It helps confirm the diagnosis, supports medical management, and enables genetic counselling for at-risk family members.

How to Prepare

  • No special diet or fasting is required.
  • Inform the lab if you are taking any supplements or anticoagulant medications.
  • For FTA card, allow the blood spot to air dry completely before sealing in the provided envelope.
  • Ensure all patient identifiers are correctly written on the sample label and requisition form.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic testing is essential for confirming mitochondrial disorders such as MERRF/MELAS overlap syndrome because clinical presentation alone can be misleading. A definitive molecular diagnosis helps in informed family planning and management."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml (or as per protocol)
ContainerEDTA vacutainer / FTA card
Collection MethodPeripheral venipuncture / Finger-prick blood spot

Sample Stability

Up to 7 days
Up to 72 hours
Up to 1 month
Sample Rejection Criteria:
  • Hemolyzed blood sample
  • Incorrectly labeled sample
  • Clotted blood sample without anticoagulant
  • Sample exposed to extreme temperatures
  • Insufficient amount of sample

Understanding Your Results

The MT-TS2 gene NGS test result is interpreted in the context of clinical symptoms, family history, and other laboratory findings. A positive result indicates the presence of a pathogenic or likely pathogenic variant in the MT-TS2 gene, supporting a diagnosis of MERRF/MELAS overlap syndrome.
📊

Positive - Pathogenic variant detected

Confirms molecular diagnosis of MT-TS2-related MERRF/MELAS overlap syndrome. Recommends genetic counselling and family screening.

📊

Positive - Likely pathogenic variant detected

Suggests a strong likelihood of the disorder; further clinical correlation is advised.

📊

Negative - No pathogenic variant detected

Does not rule out MERRF/MELAS overlap syndrome; consider other mitochondrial or nuclear genes, or further testing such as mitochondrial genome sequencing.

📊

Variant of Uncertain Significance (VUS)

A detected variant with unknown clinical significance; additional familial testing or functional studies may help clarify.

⚠️ When to Consult a Doctor:

Consult your referring neurologist or geneticist if your result is positive or if you have persistent neurological symptoms despite a negative test. Seek urgent medical attention if you experience seizures, stroke-like episodes, or sudden visual loss.

Limitations

  • This test only analyses the MT-TS2 gene and does not rule out other mitochondrial or nuclear genetic causes.
  • Mutations in other mitochondrial tRNA genes or nuclear-encoded mitochondrial genes may not be detected.
  • Low-level heteroplasmy (<5-10%) may not be reliably detected depending on sequencing depth.
  • This test does not detect large deletions, duplications, or rearrangements in the mitochondrial genome.
  • A negative result does not exclude the diagnosis of MERRF/MELAS overlap syndrome; clinical correlation and further testing may be required.

Risks & Considerations

  • No significant physical risks are associated with the blood draw. Potential minor effects may include bruising or light-headedness.
  • Psychological stress due to potential positive results for a genetic disorder.
  • Risk of unsolicited information regarding family members.
  • Low, but possible, chance of misinterpretation without proper genetic counselling.

Interfering Factors

  • Sample contamination with maternal DNA
  • Low DNA quality or quantity
  • Incomplete coverage of MT-TS2 gene due to technical issues
  • Mitochondrial DNA heteroplasmy with a low mutant load

Compare With Similar Tests

TestMT-TS2 Gene MERRF/MELAS overlap syndrome, MT-TS2 related NGS Genetic TestMT-TS2 NGS Genetic TestMitochondrial Genome NGS TestNuclear Mitochondrial Gene Panel
ComparisonMT-TS2 Gene MERRF/MELAS overlap syndrome, MT-TS2 related NGS Genetic Test

Frequently Asked Questions

What is the MT-TS2 gene test?
The MT-TS2 gene test is a targeted next-generation sequencing (NGS) test that analyzes the MT-TS2 mitochondrial gene for mutations associated with MERRF/MELAS overlap syndrome.
What is MERRF/MELAS overlap syndrome?
It is a rare mitochondrial disorder that presents with overlapping features of MERRF and MELAS, including seizures, stroke-like episodes, myopathy, hearing loss, visual impairment, and cognitive decline.
What are the common symptoms of MT-TS2 related MERRF/MELAS overlap syndrome?
Common symptoms include seizures, stroke-like episodes, myopathy, visual impairment, hearing loss, cognitive decline, and sometimes lactic acidosis and ragged red fibers on muscle biopsy.
Why should I consider this genetic test?
This test helps confirm a clinical suspicion of MERRF/MELAS overlap syndrome by identifying a pathogenic variant in the MT-TS2 gene. A molecular diagnosis can guide patient management and genetic counselling for the family.
How is the test performed?
The test is performed using next-generation sequencing (NGS) technology. DNA is extracted from your blood sample, then the MT-TS2 gene is selectively amplified and sequenced. Bioinformatics analysis is used to detect mutations.
What type of sample is required?
The sample can be blood, extracted DNA, or one drop of blood placed on an FTA card. For blood samples, EDTA vacutainer is preferred. FTA cards are convenient for at-home collection.
Can this test detect all mitochondrial disorders?
No, this test is specific to the MT-TS2 gene. Other mitochondrial disorders may be caused by mutations in different mitochondrial genes or nuclear genes. A comprehensive mitochondrial genome test or nuclear gene panel may be needed.
What is the cost of the test?
The cost of the MT-TS2 related NGS genetic test is INR 20,000. This includes genetic counselling, laboratory testing, and a detailed clinical report along with raw data files.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for this test in over 100 cities across India. You can book online and a phlebotomist will visit your location.
How long will it take to get the results?
The turnaround time for this test is 3 to 4 weeks from the date the sample reaches the laboratory.
What does a positive result mean?
A positive result means a pathogenic or likely pathogenic variant was found in the MT-TS2 gene, confirming the genetic basis of MERRF/MELAS overlap syndrome. Genetic counselling is strongly recommended.
Does the test report include raw data?
Yes, DNA Labs India is unique in providing raw data files such as FASTQ and VCF along with the clinical test report. This ensures transparency and allows for further bioinformatics analysis if required.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.